Skip to content

Enhancement of Brain Circuit of Inhibitory Control in Obese Patients Undergoing Gastric Banding

Neuroband: The Effect of Perioperative Enhancement of the Brain Circuit of Inhibitory Control in Obese Patients Undergoing Laparoscopic Adjustable Gastric Banding (LAGB)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01632280
Acronym
Neuroband
Enrollment
14
Registered
2012-07-02
Start date
2012-06-30
Completion date
2018-07-31
Last updated
2019-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Obesity, Gastric Banding, Transcranial Direct Current Stimulation

Brief summary

In this project the investigators aim to improve eating control and weight loss outcomes in patients undergoing LAGB with an innovative brain-based intervention. Specifically, the investigators will enhance the activity of the right inferior frontal gyrus, a core region of the brain circuit of inhibitory control, using transcranial direct current stimulation (tDCS).

Detailed description

Laparoscopic Adjustable Gastric Banding (LAGB) is a minimally invasive and reversible procedure in bariatric surgery that has a good safety record. Despite these advantages, success rates following LAGB are quite variable across individuals. Recent data suggest that complementing LAGB with interventions targeting factors along the brain-behavior spectrum could enhance weight loss results following this procedure. The study will have the following three aims: Aim #1: To evaluate whether enhancement of the right inferior frontal gyrus with tDCS in patients undergoing LAGB can improve inhibitory control capacity. For this aim the investigators will evaluate participants' performance in a computerized test of inhibitory control. Results from this aim will provide evidence for target engagement, and thus confirm that the brain circuit of interest was affected as a result of the intervention. Aim #2: To examine whether enhancement of the right inferior frontal gyrus with tDCS in patients undergoing LAGB can lead to improvements in a self-reported measure of eating control (disinhibition subscale of the three-factor eating questionnaire). Results form this aim will provide evidence for an effect of the intervention on an intermediate, behavioral variable. Aim #3: To preliminary evaluate whether enhancement of the right inferior frontal gyrus with tDCS in patients undergoing LAGB can improve postoperative weight loss outcomes. This aim will provide preliminary evidence for the clinical efficacy of the intervention over a time window period of 12 months. Weight loss at 12 months will be the primary outcome of the study.

Interventions

DEVICETranscranial Direct Current Stimulation (tDCS)

tDCS is a well-established, safe and noninvasive neuromodulation technique that is based on the application of a weak direct current to the scalp that flows between two electrodes-anode and cathode. Although there is substantial shunting of current in the scalp, sufficient current penetrates the brain to modify the transmembrane neuronal potential, and thus influence the level of excitability and modulate the firing rate of individual neurons. In this study, participants will receive 10 daily sessions of tDCS (sham/real) over a period of two weeks.

Sponsors

Boston Medical Center
CollaboratorOTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
Beth Israel Deaconess Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Age: 20-55 years old * BMI: 35-60 kg/m2 * Planning to undergo or having undergone laparoscopic adjustable gastric banding (LAGB) within the previous week

Exclusion criteria

* Unstable medical conditions including poorly controlled diabetes and hypertension * Pregnancy or planning pregnancy during study period * Personal or family history of epilepsy or other unexplained loss of consciousness * Current or past medical history of skin disease or damaged skin on the scalp at site of stimulation * Active psychiatric or neurological condition * Prior neurological procedure * Implanted pacemaker, medication pump, vagal stimulator, deep brain stimulator, TENS unit, or ventriculoperitoneal shunt * Intake of common medications that affect the central nervous system will be allowed if determined okay by MD

Design outcomes

Primary

MeasureTime frameDescription
Weight ChangeBaseline, 2 weeks after surgery, 10 days of tDCS, 1 month, 3 months, 6 months and 12 months follow upParticipants will be weighed at the indicated time points. Weight loss at 12 months will be the primary outcome of the study.

Secondary

MeasureTime frameDescription
Eating Disinhibition as Measured by the Three Factor Eating Questionnaire (TFEQ)Baseline and 12 months follow upEating Disinhibition is an eating behavior trait that reflects a tendency towards overeating and eating opportunistically in an obesogenic environment. Examples include eating in response to negative affect, overeating when others are eating, not being able to resist temptations to eat, and overeating in response to the palatability of food (Bryant, King and Blundell. Obes Rev. 2008;9:409-19). Eating disinhibition was measured using the Three Factor Eating Questionnaire (TFEQ), which contains 16 questions for this factor. Responses are scored 0 or 1 and summed, thus eating disinhibition score ranges from 0 to 16. Higher scores denote higher levels of eating disinhibition.
Change From Baseline in Inhibitory Control Over Food as Measured by the Stop Signal Reaction Task12 month follow-up vs. BaselineInhibitory control over food was measured with a Stop Signal Task that was modified with the presence of distractors of two types: images of food and neutral images (control). The Stop Signal Task is a computerized task that evaluates an individual's ability to interrupt a motor response after its initiation (Logan 1994). Subjects were asked to press a response key matching the direction of an arrow, but refrain from pressing when an auditory cue (stop signal) appeared (25% trials). The main outcome of the task is the Stop-Signal-Reaction-Time (SSRT), in milliseconds, which reflects how long it takes to inhibit a response when a stop signal appears. The SSRT is considered a laboratory measure of inhibitory control capacity. Shorter SSRT reflects more efficient inhibitory control. Here a reduction of SSRT from baseline to 12 months indicates improvement in inhibitory capacity. We provide SSRT changes for food and neutral images, reflecting specific and general effects, respectively.

Countries

United States

Participant flow

Recruitment details

Participants were recruited between June 2012 and July 2014 from the Weight Loss Surgery Center at Beth Israel Deaconess Medical Center.

Pre-assignment details

2 participants withdrew from the study after enrollment but prior to assignment to a treatment arm.

Participants by arm

ArmCount
Active tDCS
In this arm, participants received 10 daily sessions of active Transcranial Direct Current Stimulation (2mA, 20 min per session) over the course of two weeks. The anode electrode was placed over the right inferior frontal gyrus, defined as F8 (10-20 EEG system), with the cathode electrode placed over the contralateral supraorbital area, above the left eyebrow. During each session participants performed a computerized task designed to engage the inhibitory control circuit when confronted with food stimuli.
6
Sham tDCS
In this arm, participants received 10 daily sessions of sham Transcranial Direct Current Sitmulation with the same duration and electrode montage as in the real tDCS arm (20 minutes, targeting the right inferior frontal gyrus). In this case, current was applied for 30 s only according to standard procedures, and participants performed a control task during which they observed and provided responses for the same food and non-food pictures as in the active group task, but without the requirement of inhibitory control for performance.
6
Total12

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyWithdrawal by Subject10

Baseline characteristics

CharacteristicActive tDCSSham tDCSTotal
Age, Continuous42.3 years
STANDARD_DEVIATION 8
44.3 years
STANDARD_DEVIATION 7.1
43.3 years
STANDARD_DEVIATION 7.3
Sex: Female, Male
Female
4 Participants4 Participants8 Participants
Sex: Female, Male
Male
2 Participants2 Participants4 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 60 / 6
other
Total, other adverse events
6 / 66 / 6
serious
Total, serious adverse events
0 / 60 / 6

Outcome results

Primary

Weight Change

Participants will be weighed at the indicated time points. Weight loss at 12 months will be the primary outcome of the study.

Time frame: Baseline, 2 weeks after surgery, 10 days of tDCS, 1 month, 3 months, 6 months and 12 months follow up

Population: 1 Participant withdrew prior to obtaining outcome data at the 10th day of tDCS, 1 participant was lost to follow-up prior to the 3-month follow-up visit, and 1 participants were lost to follow-up prior to obtaining outcome data at the 6-month follow-up visit.

ArmMeasureGroupValue (MEAN)Dispersion
Active tDCSWeight Change10th day of tDCS280.4 pounds (lbs)Standard Deviation 62.1
Active tDCSWeight Change3 month follow-up268 pounds (lbs)Standard Deviation 52.1
Active tDCSWeight Change2 weeks post gastric band (LAGB) surgery273.4 pounds (lbs)Standard Deviation 62.7
Active tDCSWeight Change6 month follow-up278.05 pounds (lbs)Standard Deviation 52.5
Active tDCSWeight Change1 month follow-up273.4 pounds (lbs)Standard Deviation 57
Active tDCSWeight Change12 month follow-up289.8 pounds (lbs)Standard Deviation 58.8
Active tDCSWeight ChangeBaseline285.0 pounds (lbs)Standard Deviation 63.8
Sham tDCSWeight Change12 month follow-up204.2 pounds (lbs)Standard Deviation 30.5
Sham tDCSWeight ChangeBaseline245.3 pounds (lbs)Standard Deviation 41
Sham tDCSWeight Change2 weeks post gastric band (LAGB) surgery228.4 pounds (lbs)Standard Deviation 34.8
Sham tDCSWeight Change10th day of tDCS225.8 pounds (lbs)Standard Deviation 34
Sham tDCSWeight Change1 month follow-up220.3 pounds (lbs)Standard Deviation 34.1
Sham tDCSWeight Change3 month follow-up210.6 pounds (lbs)Standard Deviation 34.9
Sham tDCSWeight Change6 month follow-up206.5 pounds (lbs)Standard Deviation 31
Secondary

Change From Baseline in Inhibitory Control Over Food as Measured by the Stop Signal Reaction Task

Inhibitory control over food was measured with a Stop Signal Task that was modified with the presence of distractors of two types: images of food and neutral images (control). The Stop Signal Task is a computerized task that evaluates an individual's ability to interrupt a motor response after its initiation (Logan 1994). Subjects were asked to press a response key matching the direction of an arrow, but refrain from pressing when an auditory cue (stop signal) appeared (25% trials). The main outcome of the task is the Stop-Signal-Reaction-Time (SSRT), in milliseconds, which reflects how long it takes to inhibit a response when a stop signal appears. The SSRT is considered a laboratory measure of inhibitory control capacity. Shorter SSRT reflects more efficient inhibitory control. Here a reduction of SSRT from baseline to 12 months indicates improvement in inhibitory capacity. We provide SSRT changes for food and neutral images, reflecting specific and general effects, respectively.

Time frame: 12 month follow-up vs. Baseline

Population: 1 participant withdrew prior to the 12 month follow-up and 2 participants were lost to follow-up prior to the 12 month follow-up.

ArmMeasureGroupValue (MEAN)Dispersion
Active tDCSChange From Baseline in Inhibitory Control Over Food as Measured by the Stop Signal Reaction TaskChange, stop signal reaction time, food images-72.6 milliseconds (ms)Standard Deviation 68.3
Active tDCSChange From Baseline in Inhibitory Control Over Food as Measured by the Stop Signal Reaction TaskChange, stop signal reaction time, neutral images-62.3 milliseconds (ms)Standard Deviation 77.8
Sham tDCSChange From Baseline in Inhibitory Control Over Food as Measured by the Stop Signal Reaction TaskChange, stop signal reaction time, food images-51.1 milliseconds (ms)Standard Deviation 49.8
Sham tDCSChange From Baseline in Inhibitory Control Over Food as Measured by the Stop Signal Reaction TaskChange, stop signal reaction time, neutral images-46.4 milliseconds (ms)Standard Deviation 67.7
Secondary

Eating Disinhibition as Measured by the Three Factor Eating Questionnaire (TFEQ)

Eating Disinhibition is an eating behavior trait that reflects a tendency towards overeating and eating opportunistically in an obesogenic environment. Examples include eating in response to negative affect, overeating when others are eating, not being able to resist temptations to eat, and overeating in response to the palatability of food (Bryant, King and Blundell. Obes Rev. 2008;9:409-19). Eating disinhibition was measured using the Three Factor Eating Questionnaire (TFEQ), which contains 16 questions for this factor. Responses are scored 0 or 1 and summed, thus eating disinhibition score ranges from 0 to 16. Higher scores denote higher levels of eating disinhibition.

Time frame: Baseline and 12 months follow up

Population: 1 participant withdrew prior to the 12 month follow-up and 2 participants were lost to follow-up prior to the 12 month follow-up.

ArmMeasureGroupValue (MEAN)Dispersion
Active tDCSEating Disinhibition as Measured by the Three Factor Eating Questionnaire (TFEQ)Baseline7.0 units on a scaleStandard Deviation 5.4
Active tDCSEating Disinhibition as Measured by the Three Factor Eating Questionnaire (TFEQ)12 month follow-up5.0 units on a scaleStandard Deviation 1.2
Sham tDCSEating Disinhibition as Measured by the Three Factor Eating Questionnaire (TFEQ)Baseline3.8 units on a scaleStandard Deviation 2.1
Sham tDCSEating Disinhibition as Measured by the Three Factor Eating Questionnaire (TFEQ)12 month follow-up3.6 units on a scaleStandard Deviation 4.2

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026